Patrick Mismetti

Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network

Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis

Platelet Inflammatory Response to Stress

Direct oral anticoagulants are associated with limited damage of endothelial cells of the blood-brain barrier mediated by the thrombin/PAR-1 pathway

Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies

The management of acute venous thromboembolism in clinical practice

Pharmacokinetic/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass

Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015

The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry

Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation

Prevention of Venous Thromboembolic Events With Low‐Molecular‐Weight Heparin in the Non‐Major Orthopaedic Setting: Meta‐Analysis of Randomized Controlled Trials

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism